Gout is the most treatable arthritis in the Western World—the pathophysiology of which is related to uric acid metabolism and there are effective medications available to treat both acute arthritis and chronic hyperuricemia. Despite this many patients continue to suffer from tophaceous gout with major detrimental effects on patient-reported outcomes and substantial economic impact. Poor adherence to medications is considered an important attribute in developing disability due to gout. This review summarizes recommendations from various national and international guidelines with an update on the therapeutics.
CITATION STYLE
Khanna, P. P. (2016). Gout Transitions from Medieval Times into the 21 Century. The Open Urology & Nephrology Journal, 9(Suppl 1: M4), 22–26. https://doi.org/10.2174/1874303x01609010022
Mendeley helps you to discover research relevant for your work.